ING Groep NV Buys New Stake in Mettler-Toledo International, Inc. $MTD

ING Groep NV bought a new stake in Mettler-Toledo International, Inc. (NYSE:MTD) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,640 shares of the medical instruments supplier’s stock, valued at approximately $2,286,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. EverSource Wealth Advisors LLC grew its holdings in shares of Mettler-Toledo International by 2.4% in the third quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock valued at $361,000 after purchasing an additional 7 shares in the last quarter. Allworth Financial LP grew its holdings in shares of Mettler-Toledo International by 6.1% in the third quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock valued at $149,000 after purchasing an additional 7 shares in the last quarter. Evergreen Capital Management LLC grew its holdings in shares of Mettler-Toledo International by 4.5% in the fourth quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock valued at $257,000 after purchasing an additional 8 shares in the last quarter. Meridian Wealth Management LLC grew its holdings in shares of Mettler-Toledo International by 1.7% in the fourth quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock valued at $680,000 after purchasing an additional 8 shares in the last quarter. Finally, Verdence Capital Advisors LLC grew its holdings in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock valued at $639,000 after purchasing an additional 9 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Stock Up 2.0%

Shares of MTD opened at $1,161.76 on Wednesday. The company has a market cap of $23.48 billion, a PE ratio of 27.25, a P/E/G ratio of 2.37 and a beta of 1.27. The business has a fifty day moving average of $1,211.50 and a 200 day moving average of $1,319.07. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.Mettler-Toledo International’s revenue was up 7.2% on a year-over-year basis. During the same period last year, the company earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, research analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.

Analysts Set New Price Targets

MTD has been the subject of a number of recent research reports. Stifel Nicolaus cut their target price on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Citigroup lowered their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Wolfe Research started coverage on Mettler-Toledo International in a research report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Barclays lowered their price target on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Morgan Stanley lowered their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 12th. Six research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $1,408.55.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.